Kenneth L. Waggoner's Net Worth

-$1.02 Million

Estimate Recalculated Jul 17, 2024 04:00PM EST

Who is Kenneth L. Waggoner?

Kenneth L. Waggoner does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include VelaTel Global Communications, Inc., and PharmaCyte Biotech, Inc..

SEC CIK

Kenneth L. Waggoner's CIK is 0001464611

Past Insider Trading and Trends

2012 was Kenneth L. Waggoner's most active year for acquiring shares with 8 total transactions. Kenneth L. Waggoner's most active month to acquire stocks was the month of May. 2012 was Kenneth L. Waggoner's most active year for disposing of shares, totalling 43 transactions. Kenneth L. Waggoner's most active month to dispose stocks was the month of September. 2009 saw Kenneth L. Waggoner paying a total of $534,054.40 for 4,587,568 shares, this is the most they've acquired in one year. In 2012 Kenneth L. Waggoner cashed out on 2,041,898 shares for a total of $73,923.86, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

VelaTel Global Communications, Inc. No price found

EVP Legal, Genl Counsel & Secy

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+495.58%
2.28M
$0.04
$109,520.74
2.75M
Nov 29 - Jan 15
Form 4/A
-54.27%
-23.50K
$0.05
-$1,275.00
19.8K
Nov 28 - Nov 29
Form 4
-54.27%
-23.50K
$0.54
-$12,750.00
19.8K
Nov 28 - Nov 29
Form 4
-49.17%
-119.10K
$0.05
-$4,634.66
123.11K
Oct 22 - Oct 23
Form 4
-21.56%
-47.40K
$0.03
-$1,261.34
172.41K
Oct 9 - Oct 11
Form 4
-11.91%
-100.00K
$0.03
-$2,895.00
739.41K
Oct 2 - Oct 5
Form 4
-7.05%
-25.00K
$0.03
-$667.50
329.81K
Sep 26 - Oct 2
Form 4
-1.39%
-5.00K
$0.04
-$200.00
354.81K
Sep 20
Form 4
-3.22%
-24.00K
$0.05
-$1,171.00
720.61K
Aug 31 - Sep 14
Form 4/A
-11.63%
-50.00K
$0.05
-$2,500.00
379.81K
Sep 6
Form 4
-11.53%
-50.00K
$0.05
-$2,500.00
383.81K
Sep 6
Form 4
+333.85%
333.82K
$0.08
$28,040.54
433.81K
Aug 30
Form 4
-1.68%
-3.44K
$0.09
-$309.60
201.51K
Aug 28 - Aug 29
Form 4
-6.76%
-7.50K
$0.23
-$1,755.00
103.43K
Aug 7 - Aug 9
Form 4
∞
22.06M
—
$22,060.61
22.06M
Jul 18
Form 4
-2.20%
-250.00K
$0.01
-$1,800.00
11.09M
Jul 16
Form 4
-1.73%
-200.00K
$0.01
-$1,900.00
11.34M
Jul 9 - Jul 10
Form 4
+23.75%
2.22M
$0.01
$25,478.60
11.54M
Jun 29
Form 4
-1.20%
-113.46K
$0.01
-$1,304.77
9.33M
Jun 27 - Jun 28
Form 4
+35.57%
2.48M
$0.02
$44,342.72
9.44M
Jun 1
Form 4
+19.56%
1.14M
$0.02
$25,518.75
6.96M
May 2
Form 4
+27.15%
1.24M
$0.03
$36,936.91
5.82M
Apr 2
Form 4
-17.92%
-1.00M
$0.04
-$37,000.00
4.58M
Mar 22
Form 4
—
0
—
—
0
Jul 15
Form 4
+86.37%
2.59M
$0.04
$94,399.62
5.58M
Feb 29
Form 4
-1.36%
-41.21K
$0.22
-$9,185.32
2.99M
Oct 19
Form 4
+15.47%
406.75K
$0.55
$221,681.48
3.04M
Apr 8
Form 4
-1.50%
-40.00K
$0.68
-$27,255.00
2.63M
Mar 29
Form 4
-0.56%
-15.00K
$0.98
-$14,700.00
2.67M
Mar 5
Form 4
+28.03%
587.57K
$0.80
$470,054.40
2.68M
Jul 29
Form 4/A
+2,078.87%
2M
$0.03
$64,000.00
2.1M
Jun 17
Form 4
+2,078.87%
2M
—
—
2.1M
Jun 17
Form 3
—
0
—
—
0
No matching records found

PharmaCyte Biotech, Inc. (PMCB) Snapshot price: $2.3

Chairman, CEO, Pres and GC

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found